Andrew Wilber

Department of Medical Microbiology, Southern Illinois University School of Medicine

Affiliated withSouthern Illinois University School of Medicine Simmons Cancer Institute

Research Area

Cancer Research

Biography

Andrew Wilber has not added Biography.
If you are Andrew Wilber and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2017

Other Publications

Article	Year
Deoxyribonuclease I-like III is an inducible macrophage barrier to liposomal transfection. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 12095301	2002
A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 15964244	2005
Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system. Blood\| PubMed ID: 16189271	2006
Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging. Human gene therapy\| PubMed ID: 16259566	2005
RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 16368272	2006
Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon. BMC biotechnology\| PubMed ID: 16800892	2006
Harnessing a high cargo-capacity transposon for genetic applications in vertebrates. PLoS genetics\| PubMed ID: 17096595	2006
Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 17440442	2007
Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem cells (Dayton, Ohio)\| PubMed ID: 17673526	2007
A facile method for somatic, lifelong manipulation of multiple genes in the mouse liver. Hepatology (Baltimore, Md.)\| PubMed ID: 18435462	2008
Liver-directed gene therapy using the sleeping beauty transposon system. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 18470650	2008
DNA transposons for modification of human primary T lymphocytes. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 19110623	2009
Gene expression in lung and liver after intravenous infusion of polyethylenimine complexes of Sleeping Beauty transposons. Human gene therapy\| PubMed ID: 19761403	2010
Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood\| PubMed ID: 19901262	2010
Roles of inflammation in cancer initiation, progression, and metastasis. Frontiers in bioscience (Scholar edition)\| PubMed ID: 20036938	2010
Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer. Human gene therapy\| PubMed ID: 20163250	2010
A zinc-finger transcriptional activator designed to interact with the gamma-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts. Blood\| PubMed ID: 20190190	2010
Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells. Human gene therapy\| PubMed ID: 20528476	2010
Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer. Blood\| PubMed ID: 21156846	2011
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast cancer research and treatment\| PubMed ID: 21188630	2011
Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities. Blood\| PubMed ID: 21321359	2011
A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine. PloS one\| PubMed ID: 21412438	2011
Efficient non-viral integration and stable gene expression in multipotent adult progenitor cells. Stem cells international\| PubMed ID: 21977042	2011
Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer research\| PubMed ID: 22113945	2012
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. The Journal of experimental medicine\| PubMed ID: 22124112	2011
Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells. The Biochemical journal\| PubMed ID: 22329800	2012
Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy. Neoplasia (New York, N.Y.)\| PubMed ID: 23097627	2012
Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain. EMBO molecular medicine\| PubMed ID: 23495140	2013
Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells. Experimental hematology\| PubMed ID: 25681747	2015
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells. Blood\| PubMed ID: 25733580	2015
A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter. PloS one\| PubMed ID: 25823013	2015
Partial nephrectomy for T2 renal masses: contemporary trends and oncologic efficacy. International urology and nephrology\| PubMed ID: 25864101	2015
Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma. Human vaccines & immunotherapeutics\| PubMed ID: 25996049	2015
Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells. Molecular therapy. Methods & clinical development\| PubMed ID: 26665131	2015
Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis. Oncotarget\| PubMed ID: 26885613	2016
Fas-antisense long noncoding RNA is differentially expressed during maturation of human erythrocytes and confers resistance to Fas-mediated cell death. Blood cells, molecules & diseases\| PubMed ID: 27067490	2016
Data in support of transcriptional regulation and function of Fas-antisense long noncoding RNA during human erythropoiesis. Data in brief\| PubMed ID: 27141526	2016